Eligo Bioscience

Eligo Bioscience
Eligo Bioscience
Eligobiotics, a new generation of antimicrobials that can be programmed to target bacteria based on their genome. Eligobiotics therefore provide a new approach to explore, understand and control bacterial ecosystems both in human and animals. They can notably be used to selectively eradicate harmful pathogens from the microbiome while sparing beneficial ones.
BioTech, Science Tech, MedTech

Articles about Eligo Bioscience:

💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Eligo Bioscience? We’re happy to assist you with our Startup Sourcing service.